$2,487.29 speaking Payment -- Johnson & Johnson to Dr. James Wilson

General Surgeon James Wilson Receives Speaker Fee from Johnson & Johnson

This page provides a detailed analysis of a $2,487.29 speaking payment from Johnson & Johnson to Dr. James Wilson. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

Field	Value
Amount	$2,487.29
Payment Type	speaking
Payment Nature	Compensation for serving as faculty or as a speaker
Pharmaceutical Company	Johnson & Johnson
Physician	Dr. James Wilson
NPI Number	1892402415
Physician Specialty	General Surgery
Location	City, IN
Date of Payment	2025-12-07
Conflict Assessment	Low -- Routine

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Johnson & Johnson made a $2.5K speaking payment to James Wilson, a General Surgery specialist in City, IN. Dr. James Wilson received $2,487.29 from Johnson & Johnson on December 7, 2025. The payment was for serving as faculty or a speaker. This payment falls under the 'speaking' category.

Patient Guidance: What This Payment Means for You

This payment represents compensation for a physician's role in educating others, not for personal medical services. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Payments for speaking engagements are common in the pharmaceutical industry, particularly for physicians who share expertise with peers.

Regulatory Context: Sunshine Act Requirements

This payment is reportable under the Physician Payments Sunshine Act, requiring disclosure of transfers of value from manufacturers to physicians.

Understanding speaking Payments

Speaking and education payments compensate physicians for presenting at conferences, continuing medical education (CME) events, and promotional speaking engagements. These payments often cover honoraria, preparation time, and travel expenses. Speaking fees are among the highest-value payment categories and have attracted significant attention from researchers studying potential conflicts of interest.

Frequently Asked Questions About This Payment

What was this $2.5K payment for?

This was a speaking payment of $2.5K from Johnson & Johnson to James Wilson, categorized as "Compensation for serving as faculty or as a speaker". The payment was reported under the Sunshine Act (CMS Open Payments).

Does James Wilson accept pharmaceutical money?

Yes, James Wilson received this $2.5K payment from Johnson & Johnson. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view James Wilson's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this speaking payment?

A speaking payment of $2.5K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in General Surgery?

To compare this payment against General Surgery averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. General Surgery physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about James Wilson's relationship with Johnson & Johnson?

The payment amount is $2,487.29. This $2.5K speaking payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for General Surgery?

The payment was made by Johnson & Johnson.

What should patients do after learning about this payment?

This payment represents compensation for a physician's role in educating others, not for personal medical services.

What else should I know about this speaking payment?

The date of payment is December 7, 2025.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.